BibTex RIS Cite

Hematopoietic Stem Cell Transplantation in Patients with Beta Thalassemia Major

Year 2014, Volume: 23 Issue: 1, 49 - 59, 30.10.2014
https://doi.org/10.17827/aktd.22596

Abstract

Hemoglobinopathies include an enormous patient population in south part of Turkey. Allogeneic hematopoietic stem cell transplantation is only curative treatment in thalassemia. Optimal medical therapy is very important in the years before transplant to achieve a successful transplantation. In this study, the indications, risk factors, results and the situation related with hematopoietic stem cell transplantation in thalassemia in Turkey was reviewed.

References

  • Smiers FJ, Krishnamurti L, Lucarelli G. Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends. Pediatr Clin North Am. 2010; 57:18120
  • Thomas ED, Buckner CD, Sanders JE, Papayannopoulou T, Borgna-Pignatti C, De Stefano P et al. Marrow transplantation for thalassemia. Lancet. 1982; 2:227-8.
  • Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Bone marrow transplantation in patients with thalassemia. N Eng J Med. 1990; 322:417-21. Mathews V, George B, Deotare U, Lakshmi KM, Viswabandya A, Daniel D et al. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007; 13:889-94.

Beta Talasemi Majorlu Hastalarda Hematopoetik Kök Hücre Transplantasyonu

Year 2014, Volume: 23 Issue: 1, 49 - 59, 30.10.2014
https://doi.org/10.17827/aktd.22596

Abstract

Hemoglobinopatiler ülkemizin özellikle güney bölümünde önemli bir hasta populasyonunu kapsamaktadır. Talasemide küratif tek tedavi yöntemi allojenik hematopoetik kök hücre naklidir. Nakilden önceki yıllarda uygun medikal tedavinin verilmesi transplantın başarısı açısından çok önemlidir. Bu yazıda talasemideki kök hücre nakli ile ilgili endikasyonlar, risk faktörleri, sonuçlar ve Türkiye'deki durum gözden geçirilmiştir.

References

  • Smiers FJ, Krishnamurti L, Lucarelli G. Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends. Pediatr Clin North Am. 2010; 57:18120
  • Thomas ED, Buckner CD, Sanders JE, Papayannopoulou T, Borgna-Pignatti C, De Stefano P et al. Marrow transplantation for thalassemia. Lancet. 1982; 2:227-8.
  • Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Bone marrow transplantation in patients with thalassemia. N Eng J Med. 1990; 322:417-21. Mathews V, George B, Deotare U, Lakshmi KM, Viswabandya A, Daniel D et al. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007; 13:889-94.
There are 3 citations in total.

Details

Primary Language Turkish
Journal Section Review
Authors

M. Akif Yeşilipek This is me

Publication Date October 30, 2014
Published in Issue Year 2014 Volume: 23 Issue: 1

Cite

AMA Yeşilipek MA. Beta Talasemi Majorlu Hastalarda Hematopoetik Kök Hücre Transplantasyonu. aktd. March 2014;23(1):49-59. doi:10.17827/aktd.22596